Abstract
The role of thymectomy in the management of myasthenia gravis is reviewed in the light of the published data and of a personal series. The patients in whom the operation is most successful are non thymomatous patients aged between 10 and 40 years with an MG history of less than 3 years. There is no sex prevalence. Lasting improvement may be expected. There are no proven correlations between biological indices like the germinal centers in the thymus and/or AChR antibody titers and the postoperative course of the disease. Complete removal of the thymus seems to be crucial and hence the transsternal approach is preferred. The operation, less effective in patients with thymona than in those with an active thymus, is nonetheless necessary to in these patients prevent putative damage to surrounding organs from thymona infiltration. Why thymectomy should be effective in patients with an active thymus and not in those with a thymona may be revealed by in vitro studies of the interactions between thymic cells and peripheral B cells, now in progress.
Sommario
Viene rivisto alla luce dei dati della letteratura e della casistica personale il ruolo della timectomia nella terapia della miastenia. Dei pazienti non portatori di timoma i migliori risultati si ottengono in quelli di età fra i 10 e i 40 anni con una durata della malattia minore di tre anni. Non vi è prevalenza di sesso. Ci si può attendere un miglioramento duraturo. Non vi sono prove di una correlazione tra gli indici biologici germinativi quali i centri germinali nel timo e o il titolo degli anticorpi contro i ricettori acetilcolinici e il decorso post-operatorio della malattia. É fondamentale la completa asportazione del timo e perciò è preferibile la scelta della tecnica di approccio transternale.
Nei pazienti con timoma la timectomia è meno efficace ma l'intervento è necessario per evitare danni derivanti dall'infiltrazione del timoma sugli organi circostanti. Il perché della efficacia della timectomia nei pazienti con un timo attivo ma non in quelli con timoma potrà essere chiarito dagli studi in vitro sulle interazioni tra cellule timiche e quelle periferiche B, studi che sono ormai in stadio avanzato.
Article PDF
Avoid common mistakes on your manuscript.
References
Bach J.F., Papiernik M., Levasseur P., Dardenne M., Barois A., Brigand H. Le:Evidence for a serum-factor secreted by the human thymus. Lancet II: 1056–1058, 1972
Batata M.A., Martini N., Huvos A.G., Aguilar R.I., Beattie E.J.:Thymomas: clinicopathologic features, therapy and prognosis. Cancer 34: 389–395, 1974
Bergh N.P., Gatzinski P., Larsson S., Lundin P., Ridell B.:Tumors of the thymus and thymic region; clinicopathological studies on thymomas. Ann Thor Surg 25: 91–98, 1978
Bergmans J.:Apport des techniques neuro-physiologiques à la surveillance de patients myasthéniques, en particulier à l'occasion de la thymectomie. Ann Chir: Chir Thoraco-Cardiovasc 34: 182–187, 1980
Binét J.P., Pouliquen E., Razafinombana A., Brigand H le, Lasfarques G.:Thymectomie pour myasthénie chez le jeune enfant. Bull Acad Nat Méd 164: 665–669, 1980
Blalock A., Mason M.F., Morgan H.J., Riven S.S.:Myasthenia gravis and tumors of the thymic region. Report of a case in which the tumor was removed. Ann Surg 110: 544–560, 1939
Blalock A.:Thymectomy in the treatment of myasthenia gravis. J Thor Surg 13: 316–339, 1944
Brigand H. le.Levasseur P., Miranda A.R., Gaud C., Wojakowski I.:Résultats du traitement chirurgical de la myasthénie (248 cas de thymectomies). Ann Chir: Chir Thoraco-Cardiovasc 34: 169–172, 1980
Buckingham J.M., Howard F.M., Bernatz P.E., Payne W.S., Harrison E.G., O'Brien P.C., Weiland L.H.:The value of thymectomy in myasthenia gravis. Ann Surg 184: 453–457, 1976
Castleman B., Norris E.:The pathology of the thymus in myasthenia gravis. Medicine 28: 27–59, 1949
Castleman B.:The pathology of the thymus gland in myasthenia gravis. Ann NY Acad Sci 135: 496–503, 1966
Compston D.A.S., Vincent A., Newson-Davis J., Batchelor J.R.:Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103: 579–601, 1980
Drachman D.B.:Myasthenia gravis. N Engl J Med 298: 136–142, 186–193, 1978
Eaton L.M., Clagett O.T.:Thymectomy in the treatment of myasthenia gravis: results in seventytwo cases compared with one hundred and fortytwo control cases. JAMA 142: 963–967, 1950
Eaton L.M., Clagett O.T.:Present status of thymectomy in the treatment of myasthenia gravis. Am J Med 19: 703–715, 1955
Emerijk B., Strugalska M.H.:Evaluation of results of thymectomy in myasthenia gravis. J Neurol 211: 155–168, 1976
Feltkamp T.E.W., Berg-Loonen P.M. van der,Nijenhuis L.E., Engelfriet C.P., Lothem J.J. van,Rossum A.L. van,Oosterhuis H.J.G.H.:Myasthenia gravis, autoantibodies and HLA antigens. Br Med J I: 131–133, 1974
Fonkalsrud E.W., Herrmann C., Mulder D.G.:Thymectomy for myasthenia gravis in children. J Ped Surg 5: 157–165, 1970
Geefhuysen J., Ronthal M., Rogers M.A.:Thymectomy for myasthenia gravis in Bantu children. S Afr Med J 44: 239–241, 1970
Genkins G., Papatestas A.E., Horowitz S.N., Kornfeld P.:Studies in myasthenia gravis; early thymectomy. Am J Med 58: 517–524, 1975
Goldman A.J., Hermann C., Keesey J.C., Mulder D.G., Jann Brown W.:Myasthenia gravis and invasive thymoma: a 20-year experience. Neurology 25: 1021–1025, 1975
Grob D.:Myasthenia gravis: current status of pathogenesis, clinical manifestations and management. J Chronic Dis 8: 536–566, 1958
Habgerg H., Hansson O., Holmdahl M.:Myasthenia gravis: early thymectomy in children. Opuscula Medica 12: 110–114, 1967
Hale J.F., Scowen E.F.:Thymic tumors; their association with myasthenia gravis and their treatment by radiotherapy. Lloyd-Luke Ltd. London, 1967
Hansson O., Johansson L., Stalberg E., Westerholm C.J.:Thymectomy in juvenile myasthenia gravis. Neuropädiatrie 3: 429–436, 1972
Harvey A. McG:Some preliminary observations in the clinical course of myasthenia gravis before and after thymectomy. Bull NY Acad Med 24: 505–522, 1948
Henze A.,Biberfeld P.,Christensson B.,Matell G.,Pirskanen R.,Wedlund J.E.:Is transsternal exploration worth-while in myasthenia gravis patients previously “thymectomized” by suprasternal approach. Internat Cong on Muscle Disorders, Marseille, 1982
Jaretzki A., Tethea M., Wolff M., Olarte M.R., Lovelace R.E., Penn A.S., Rowland L.:A rational approach to total thymectomy in the treatment of myasthenia gravis. Ann Thor Surg 24: 120–127, 1977
Jerusalem F.:Die Therapie der Myasthenia gravis. Deutsche Med Wochensch 32: 1160–1163, 1977
Joseph B.S., Johns T.R.:Recurrence of noneoplastic thymus after thymectomy for myasthenia gravis. Neurology 23: 109–116, 1973
Kao I., Drachman D.B.:Thymic muscle cells bear acetylcholine receptors: possible reaction to myasthenia gravis. Science 195: 74–75, 1977
Keynes G.L.:The results of thymectomy in myasthenia gravis. B Med J II: 611–616, 1949
Keynes G.L.:Surgery of the thymus gland. Lancet II: 1197–1208, 1954
Keynes G.L.:The history of myasthenia gravis. Med Hist 5: 313–325, 1961
Kirschner P.A., Osserman K.E., Kark A.E.:Studies in myasthenia gravis; trans-cervical total thymectomy. JAMA 209: 906–910, 1969
Klingen G., Johansson L., Westerhom C.J., Sundström C.:The transcervical thymectomy with the aid of mediastinoscopy for myasthenia gravis; eight years experience. Ann Thor Surg 23: 342–347, 1977
Kunze K.:Thymectomy in the treatment of myasthenia. Thor Cardiovasc Surgeon 28: 380–385, 1980
Kuzin M.I., Kusmin N.V., Kopeyeva T.N.:Remote results of surgical treatment in myasthenia. Zurnal Nevropathologii i Psihiatrii Imeni S.S. Korsakova 68: 1801–1805, 1968
Lange M.J.:Early thymectomy for myasthenia gravis. B Med J III: 284, 1975
Lattes R.:Thymoma and other tumors of the thymus: an analysis of 107 cases. Cancer 15: 1224–1260, 1962
Levine G.D., Rosai J.:Thymic hyperplasia and neoplasia: a review of current concepts. Human Pathology 9: 495–515, 1978
Limburg P.C., The T.H., Hummel-Tappel E., Oosterhuis H.J.G.H.:Anti-acetylcholine receptor antibodies in myasthenia gravis I. Their relation to the clinical state and the effect of therapy. J Neurol Sci 58: 357–370, 1983
Masaoka A., Monden Y.:Comparison of the results of transsternal simple, transcervical simple and extended thymectomy. Ann NY Acad Sci 377: 755–764, 1981
Masaoka A., Monden Y., Nakahara K., Tamioka T.:Follow-up study of thymomas with special reference to their clinical stages. Cancer 48: 2485–2492, 1981
Masaoka A., Monden Y., Seike Y., Tanioka T., Kagotani K.:Reoperation after transcervical thymectomy for myasthenia gravis. Neurology 32; 83–85, 1982
Matell G., Lebram G., Osterman P.O., Pirskanen R.:Follow up comparison of suprasternal versus transsternal method for thymectomy in myasthenia gravis. Ann NY Acad Sci 377: 844–845, 1981
Matell G.:Myasthenia gravis — an auto immune receptor disease. Acta Neurol Scand suppl. 90, 65: 112–121, 1982
Millichap J.G., Dodge Ph. R.:Diagnosis and treatment of myasthenia gravis in infancy, childhood and adolescence: a study of 51 patients. Neurology 10: 1007–1014, 1960
Mizuno Y., Shimabukuro K., Kurita K., Tsychiya M.:Thymus abnormalities in ulcerative colitis; comparative study with other auto-immune diseases; Gastroenterologia Japonica 11: 208–214, 1976
Mulder D.G., Hermann C., Buckberg G.D.:Effect of thymectomy in patients with myasthenia gravis. Am J Surg 128: 202–205, 1974
Namba T., Brunner N.G., Grob D.:Myasthenia gravis in patients with thymoma with particular reference to onset after thymectomy. Medicine 57: 411–433, 1978
Olanow C.W., Lane R.J.M., Roses A.D.:Thymectomy in late onset myasthenia gravis. Archives of Neurology 39: 82–83, 1982
Oosterhuis H.J.G.H., Feltkamp T.E.W., Geld H.W.R. van der:Studies in myasthenia gravis, Part II the relation of some clinical and immunological data. J Neurol Sci 4: 417–434, 1967
Oosterhuis H.J.G.H., Bethlem J., Feltkamp T.E.W.:Muscle pathology, thymoma and immunological abnormalities in patients with myasthenia gravis. J Neurol Neurosurg Psychiatry 31: 460–463, 1968
Oosterhuis H.J.G.H.:The relation between the histopathology of the thymus gland and the effect of thymectomy ih myasthenia gravis. In: Bradley W.G. (ed) Recent advances in myology, Excerpta Medica, 516–521, 1975
Oosterhuis H.J.G.H.:Ergebnisse der Thymectomie in Beziehung zur Thymus-histologie. In Hertel GA (eds) Myasthenia gravis, Thieme Verlag, Stuttgart, 237–241, 1977
Oosterhuis H.J.G.H.:Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann NY Acad Sci 377: 678–689, 1981
Oosterhuis H.J.G.H.:Myasthenia gravis. A review. Clin Neurol Neurosurg 83: 105–135, 1981
Oosterhuis H.J.G.H., Limburg P.C., Hummel-Tappel E., The T.H.:Anti-acetylcholine receptor antibodies in myasthenia gravis: clinical anc serological follow-up of individual patients. J Neurol Sci 38: 371–385, 1983
Oosterhuis H.J.G.H.:Myasthenia gravis. Clin Neurol Neurosurg, Monographs. Churchill Livingstone (in press), 1984
Osserman K.E., Genkins G.:Studies in myasthenia gravis: review of a twenty year experience in over 1200 patients. Mount Sinai J Med 38: 497–537, 1971
Papatestas A.E., Osserman K.E., Kark A.E.:The effect of thymectomy on the prognosis in myasthenia gravis. Mount Sinai J Med 38: 586–593, 1971
Papatestas A.E., Alpert L., Osserman K.E., Osserman R.S., Kark A.E.:Studies in myasthenia gravis; effects of thymectomy. Am J Med 50: 465–474, 1971
Papatestas A.E., Genkins G., Kornfeld P., Horowitz S., Kark A.E.:Transcervical thymectomy in myasthenia gravis. Surgery 140: 535–540, 1975
Papatestas A.E., Genkins G., Kornfeld P.:Comparison of the results of the transcervical and transsternal thymectomy in myasthenia gravis. Ann NY Acad Sci 377: 766–778, 1981
Perlo V.P., Poskanzer D.C., Schwab R.S., Viets H.R., Osserman K.E., Genkins G.:Myasthenia gravis: evaluation of treatment in 1355 patients. Neurology 16: 431–439, 1966
Perlo V.P., Arnason B., Poskanzer D., Castleman B., Schwab R.S., Osserman K.E., Papatestas A.E., Alpert L., Kark A.:The role of thymectomy in the treatment of myasthenia gravis. Ann NY Acad Sci 183: 308–315, 1971
Perlo V.P.: Arnason B., Castleman B.:The thymus gland in elderly patients with myasthenia gravis. Neurology 25: 294–295, 1975
Perlo V.P.:Symposium on therapeutic controversies; myasthenia gravis, thymectomy. Trans Am Neurol Assoc 103: 282–283, 1978
Rosai J., Levine G.D.:Tumors of the thymus. In: Atlas of tumor pathology, second series, Armed Forces Institute of Pathology, Washington D.C., fasc. 13, 1976
Ryniewicz B., Badurska B.:Follow-up of myasthenic children after thymectomy. J Neurol 217: 133–138, 1977
Rzepecki W., Laukasiewicz M.:Chirurgiczne leczenie miasténu. Polski Tygodnik Lekarski 25: 1196–1199, 1970
Sarnat H.B., McGarry J.D., Lewis J.E.:Effective treatment of infantile myasthenia gravis by combined prednisone and thymectomy. Neurology 27: 550–553, 1977
Scadding G.K., Vincent S., Newsom-Davis J., Henry K.:Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology 31: 935–943, 1981
Schwab R.R.:Evaluation of one hundred and thirty thymectomies. In Viets H.R. (ed) Myasthenia gravis; Thomas Springfield, Illinois, 597–601, 1961
Sellors H.T., Thackray A.C., Thomson A.D.:Tumors of the thymus; a review of 88 operation cases. Thorax 22: 193–220, 1967
Seybold M.E., Howard F.M., Duane D.D., Spencer Payne W., Harrison E.G.;Thymectomy in juvenile myasthenia gravis. Archives of Neurology 25: 385–392, 1971
Sghirlanzoni A., Borroni V., Brambilla A., Fiacchino F., Peluchetti D., Micoli G., Cornelio F.:Il ruolo della timectomia nel trattamento della myasthenia gravis. Anestesia e Rianimazione 19: 39–50, 1978
Simpson J.A.:Evaluation of thymectomy in myasthenia gravis. Brain 81: 112–145, 1958
Simpson J.A.:Myasthenia gravis, Muscle diseases. Excerpta Medica Congress series 199: 14–22, 1970
Simpson J.A.:Myasthenia gravis: A personal view of pathogenesis and mechanis. Muscle and Nerve I: 45–56, 151–156, 1978
Simpson J.A.:The thymus in the pathogenesis and treatment of myasthenia gravis. In: Satoyoshi E. (ed) Myasthenia gravis, Tokyo Univ Press, Tokyo, 301–307, 1981
Skeggs D.B.L.:Complications associated with the radiotherapy of thymic tumors. Proc Royal Soc Med 66: 155, 1973
Slater G., Papatestas A.E., Genkins G., Kornfeld P., Horowitz S.H., Bender A.:Thymomas in patients with myasthenia gravis. Ann Surg 188: 171–174, 1978
Sloan H.E.:The thymus in myasthenia gravis. Surgery 13: 154–174, 1943
Starr M.A.:Myasthenia gravis. J Nerv Ment Dis 39: 721–731, 1912
Tamaoki N.,Nakazato A.,Tsuchiya M.,Satoyoshi E.:Thymus pathology and effects of thymectomy in myasthenia gravis. In: Satoyoshi E. (ed) Myasthenia gravis, University of Tokyo Press, 269–282, 1981
Thomas J.A., Wilcox N., Newsom-Davis J., Janossy G.;Immunological studies of the thymus in myasthenia gravis. J Neuroimmunol 3, 319–335, 1982
Twomey J.J., Lewis V.M., Patten B.M., Goldstein G., Good R.A.:Myasthenia gravis and serum hormone activity. Am J Med 66: 639–643, 1979
Viets H.R., Schwab R.S.:Thymectomy for myasthenia gravis. Springfield Charles C. Thomas, 117–130, 1960
Vincent A., Newsom-Davis J.:Absence of antiacetylcholine receptor antibodies in congenital myasthenia gravis. Lancet I, 441–442, 1979
Wijermans P., Oosterhuis H.J.G.H., Astaldi G.C.B., Schellekens P.T.A., Astaldi A.:Thymus-dependent serum factor in non-thymectomized and thymectomized patients with myasthenia gravis. Clin Immunol Immunopathol 16: 11–18, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oosterhuis, H.J.G.H. Thymectomy in myasthenia gravis a review. Ital J Neuro Sci 4, 399–407 (1983). https://doi.org/10.1007/BF02125618
Issue Date:
DOI: https://doi.org/10.1007/BF02125618